Navigation Links
Parents Should Postpone Child Vaccine Booster: CDC
Date:12/20/2007

Recall of 1.2 million doses of the standard Hib shot means shortage could last a year, experts say

THURSDAY, Dec. 20 (HealthDay News) -- Last week's recall of vaccines against Haemophilus influenzae (Hib) by drug maker Merck has triggered a shortage of the shots, and that's led the U.S. Centers for Disease Control and Prevention (CDC) to recommend that parents delay getting their children the standard type B (Hib) vaccine booster.

Haemophilus influenzae is a group of bacteria that may cause different types of infections in infants and children. They include ear, eye, or sinus infections and pneumonia. A more serious but rare strain can cause meningitis and a life-threatening infection called epiglottitis. H. influenzae is not a cause of the seasonal flu.

On Dec. 13, Merck recalled 1.2 million doses their Hib vaccines due to potential contamination during the manufacturing process. However, the recalled vaccine does not pose a health threat, CDC spokesman Curtis Allen said. "It's a precautionary recall. All the recalled lots have been tested, and there is no indication that there is contamination," he said.

The agency expects the shortage -- which covers Merck's PedvaxHIB and Comvax (Hib/hepatitis B) shots -- to last well into next year. The recommendation was announced Wednesday in a CDC publication, Morbidity and Mortality Weekly Report: Dispatch.

"The booster dose is being deferred temporally in order to save vaccine," Allen explained. "The deferral of boosters will likely be many months, possibly until the end of 2008."

"Parents should continue to get the initial doses of the vaccine," Allen added.

Allen noted that this delay should not cause an increase in Hib-related infections, "primarily because of the herd immunity that is afforded by the number of children who are vaccinated." In 2006, 94 percent of all U.S. children had been vaccinated, Allen said, so the chances of Hib spreading to any one child remain low -- a phenomenon doctors call "herd immunity."

However, the agency is asking that physicians keep track of patients who did not get the booster shot so they can be notified when the shortage is over, Allen said.

The Hib vaccine is recommended for all children under 5 and is usually given in a three-shot series, starting at 2 months of age. The Hib booster is recommended for children at 12 to 15 months. The delay in getting the booster will continue until the vaccine supply improves, the CDC said.

There is one exception to the recommendation, however: The agency recommends that children at high risk for Hib disease continue to receive the booster dose. Children falling into that category include American Indians, Alaska Natives and children with conditions such as asplenia, sickle cell disease, HIV, immunodeficiency conditions and certain cancers.

The CDC took this action in consultation with the its Advisory Committee on Immunization Practices, the American Academy of Pediatrics and the American Academy of Family Physicians.

More information

For more about Haemophilus influenzae type B, visit the U.S. Centers for Disease Control and Prevention.



SOURCES: Curtis Allen, spokesman, U.S. Centers for Disease Control and Prevention, Atlanta; Dec. 19, 2007, U.S. Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report: Dispatch


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Informational handout key to giving parents a better understanding of CT radiation risks
2. Many Parents Share Genetic Test Findings With Kids
3. Giving CPR Kits to Kids Nudges Parents to Learn
4. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
5. Adult offspring of parents with PTSD have lower cortisol levels
6. Parents perceptions can hamper kids asthma care, study finds
7. Parents Worries Hamper Kids Asthma Treatment
8. Parents PTSD May Boost Stress in Offspring
9. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Tips for Parents: Teaching Children to Resolve Conflicts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Parents Should Postpone Child Vaccine Booster: CDC
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved ... procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list ...
(Date:3/28/2017)... ... 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ... lot to offer to the discussion of dealing with excess skin oil. “Oily skin is ... home remedies that can help remove the oily shine while keeping the skin fresh and ...
(Date:3/27/2017)... Aurora, CO (PRWEB) , ... March 27, 2017 , ... ... Dr. Mark Braasch for leading sleep apnea treatment, with or without a referral. Sleep ... the condition, which can include daytime sleepiness, morning headaches and chronic snoring. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
(Date:3/27/2017)... 27, 2017 Summary This ... Eli Lilly and its partnering interests and activities since 2010. ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ... The report will be delivered in PDF format ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology: